Wikidata

(Q63836089)

English

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

clinical trial

In more languages

Statements

title
A PHASE 1/2 STUDY OF RO4929097, AN ORAL SMALL MOLECULE INHIBITOR OF GAMMA-SECRETASE, IN CHILDREN WITH RELAPSED/REFRACTORY SOLID OR CNS TUMORS, LYMPHOMA, OR T-CELL LEUKEMIA (English)
0 references
medical condition
lymphoma
0 references
leukemia
0 references
astrocytoma
0 references
endodermal sinus tumor
0 references
choriocarcinoma
0 references
optic nerve glioma
0 references
germinoma
0 references
craniopharyngioma
0 references
glioma
0 references
prolactinoma
0 references
teratoma
0 references
adenoma
0 references
ependymoma
0 references
meningioma
0 references
oligodendroglioma
0 references
medulloblastoma
0 references
pinealoma
0 references
adamantinoma
0 references
country
Canada
0 references
start time
March 2010
0 references
end time
May 2011
0 references
number of participants
129
0 references
maximum age
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63836089&oldid=1857473069"